Verona Pharma
VRNA
#2087
Rank
A$13.68 B
Marketcap
A$161.08
Share price
0.00%
Change (1 day)
156.44%
Change (1 year)

Operating Margin for Verona Pharma (VRNA)

Operating Margin as of December 2025 (TTM): -16.11%

According to Verona Pharma's latest financial reports and stock price the company's current Operating Margin is -16.11%. At the end of 2024 the company had an Operating Margin of -385.84%.

Operating Margin history for Verona Pharma from 2024 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-385.84%
2022-14,944.98%10654.3%
2021-138.97%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
NRC Health
NRC
22.85%-241.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-234,760.00% 1,457,131.53% Bahamas

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.